Cargando…
Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis
Amyloidosis is associated with a number of rare diseases and is characterized by the deposition, in abdominothoracic organs and peripheral nerves, of extracellular protein fibrils, which leads to dysfunction and severe morbidity. Effective clinical evaluation and management of patients with systemic...
Autores principales: | Wall, Jonathan S., Kennel, Stephen J., Martin, Emily B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469514/ https://www.ncbi.nlm.nih.gov/pubmed/28654386 http://dx.doi.org/10.1177/1536012117708705 |
Ejemplares similares
-
Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis
por: Martin, Emily B., et al.
Publicado: (2016) -
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2015) -
GATE Validation of Standard Dual Energy Corrections in Small Animal SPECT-CT
por: Lee, Sanghyeb, et al.
Publicado: (2015) -
Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide (124)I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging
por: Martin, Emily B., et al.
Publicado: (2023) -
DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)